• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

霍奇金病中治疗与带状疱疹的关系。

The relation between therapy and herpes zoster in Hodgkin's disease.

作者信息

Ramot B, Modan M, Berkowicz M, Meytes D, Shochat J

出版信息

Isr J Med Sci. 1978 Oct;14(10):1014-8.

PMID:738866
Abstract

The rate of occurrence of herpes zoster (HZ) was analyzed by the life table method in 108 Hodgkin's disease (HD) patients, diagnosed and treated during the years 1969 to 1976. Three groups, divided according to the degree of severity of the disease, were compared. The cumulative rate of occurrence of HZ at the end of the third year after diagnosis was higher in the group with intermediately extensive disease than in that with the most extensive disease (35 vs. 23%), but the difference was not significant. At the end of the fifth year, the rate was almost identical in both groups (35.3 and 35.6%, respectively). The group with the least severe form of HD had a very low HZ rate (2.2%), which was significantly different from the other two groups and close to the rate reported for normal populations. The five-year mortality rate was 0.0, 20.3 and 40.6%, respectively, in the three groups. These findings were interpreted to mean that in more advanced stages of HD, therapy and not the severity of the disease is the main factor determining the incidence of HZ. Extended field irradiation followed by a few courses of combined chemotherapy appear to have an effect similar to that of prolonged chemotherapy.

摘要

采用寿命表法分析了1969年至1976年间诊断和治疗的108例霍奇金病(HD)患者中带状疱疹(HZ)的发生率。根据疾病严重程度将患者分为三组并进行比较。诊断后第三年末,中度广泛病变组的HZ累积发生率高于最广泛病变组(35%对23%),但差异无统计学意义。第五年末,两组的发生率几乎相同(分别为35.3%和35.6%)。HD最轻型组的HZ发生率非常低(2.2%),与其他两组有显著差异,且接近正常人群报告的发生率。三组的五年死亡率分别为0.0%、20.3%和40.6%。这些发现被解释为意味着在HD的更晚期阶段,决定HZ发生率的主要因素是治疗而非疾病严重程度。扩大野照射后进行几个疗程的联合化疗似乎与长期化疗有相似的效果。

相似文献

1
The relation between therapy and herpes zoster in Hodgkin's disease.霍奇金病中治疗与带状疱疹的关系。
Isr J Med Sci. 1978 Oct;14(10):1014-8.
2
The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.一项病例对照研究表明,接受霍奇金淋巴瘤联合治疗方案的患者发生急性白血病的风险显著高于单纯接受化疗的患者,且该风险与放疗范围、化疗类型及疗程相关。
Haematologica. 1998 Sep;83(9):812-23.
3
[Questions and aspects of radiotherapy of adult patients with localized supradiaphragmatic stage (CS I/II) Hodgkin's disease. 1. Questions and aspects on indications for primary and adjuvant radiotherapy].[成人局限性膈上分期(CS I/II)霍奇金淋巴瘤患者的放疗问题及相关方面。1. 关于原发和辅助放疗适应证的问题及相关方面]
Strahlenther Onkol. 1993 Aug;169(8):449-58.
4
Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.霍奇金淋巴瘤的长期生存:死亡率、第二肿瘤、感染及心血管疾病的相对影响
Cancer J Sci Am. 1995 May-Jun;1(1):33-42.
5
Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.仅接受放疗或接受放疗加一个周期ABVD方案治疗的伴有纵隔受累的早期霍奇金病患者的复发及晚期并发症
Haematologica. 1999 Oct;84(10):917-23.
6
Second malignant tumours in childhood Hodgkin's disease.儿童霍奇金淋巴瘤中的第二原发性恶性肿瘤
Med Pediatr Oncol. 1996 Jun;26(6):373-9. doi: 10.1002/(SICI)1096-911X(199606)26:6<373::AID-MPO1>3.0.CO;2-E.
7
[Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].国际预后评分在晚期霍奇金淋巴瘤预后预测中的应用可行性研究
Ai Zheng. 2006 Aug;25(8):1013-8.
8
Analysis of the risk of solid tumor following Hodgkin's disease.霍奇金淋巴瘤后实体瘤风险分析。
Haematologica. 1997 Jan-Feb;82(1):57-63.
9
[Non-gonadic complications of chemoradiotherapy in Hodgkin's disease. A study of eighty-three patients (author's transl)].
Sem Hop. 1982 Jan 28;58(4):204-8.
10
Front-line high-dose therapy with autologous stem cell transplantation for high risk Hodgkin's disease: comparison with combined-modality therapy.一线大剂量自体干细胞移植治疗高危霍奇金淋巴瘤:与综合治疗的比较。
Bone Marrow Transplant. 2002 May;29(10):833-42. doi: 10.1038/sj.bmt.1703547.